Study of High-dose Methotrexate and Co-medications on Hepatotoxicity for Osteosarcoma Patients at a Medical Center
碩士 === 國立陽明大學 === 藥理學研究所 === 107 === Osteosarcoma (OGS) is a cancerous tumor derived from bone, which is most prevalent in children, teenagers and young adults. The current standard treatment of OGS includes surgical resection and chemotherapy. According to 2019 National Comprehensive Cancer Network...
Main Authors: | Kuan-Wei Huang, 黃冠瑋 |
---|---|
Other Authors: | Yueh-Ching Chou |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/gctwy3 |
Similar Items
-
Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
by: Wei Zhang, et al.
Published: (2016-01-01) -
The frequency of hepatotoxicity and myelotoxicity in leukemic children with different high doses of methotrexate
by: Zeynep Canan Özdemir, et al.
Published: (2016-12-01) -
Biochemical criteria of toxicity of therapy with high doses of methotrexate in children with osteosarcoma
by: A. M. Strizhevskaya, et al.
Published: (2015-06-01) -
Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy
by: Pinchasik, Dawn
Published: (2013) -
MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
by: Leilei Xu, et al.
Published: (2018-11-01)